Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975)
10/2003
10/23/2003US20030199560 Bisaryl compound and medicament for cancer treatment comprising the same
10/23/2003US20030199557 Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators
10/23/2003US20030199537 Macrocyclic lactone useful in immunosuppressant therapy
10/23/2003US20030199466 For modulating an immune response
10/23/2003US20030199460 To augment antibody production in immunized animals as well as stimulate cytokine production and activate macrophages
10/23/2003US20030199456 Sodium channel blockers
10/23/2003US20030199070 Crystallization of ribosome recycling factor (RRF) and method of developing inhibitor of RRF
10/23/2003US20030198989 For use as a diagnostic reagent for detecting the presence or absence of a target molecule in a sample; Systematic Evolution of Ligands by EXponential enrichment (SELEX)
10/22/2003EP1140745B1 Colchinol derivatives as vascular damaging agents
10/22/2003CN1450077A Method for extracting polygonum cuspidatum tannic acid
10/22/2003CN1450060A Method for producing isoforaxidin, eleutheroside and eleutheran from Radix Acanthopanacis senticosi
10/22/2003CN1125075C Method for continuous manufacture of anhydrous crystalline maltitol and manufacturing apparatus therefor
10/21/2003US6635622 Having anti-tumor activity and immunostimulating activity
10/16/2003WO2003039231A3 Compounds and methods for treating transplant rejection
10/16/2003US20030195145 Methods of treatment with combinations of statin and aryl-substituted propanolamine derivatives
10/15/2003CN1124342C Neurotrophin-3, neurotrophic factor related to nerve growth and brain derived neurotrophic factor
10/14/2003US6632799 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
10/14/2003US6632497 Hollow fibrous organic nanotube and method for producing the same
10/14/2003CA2096308C Process for preparing alkyl polyglucosides
10/09/2003WO2003082846A1 Anomeric derivatives of monosaccharides
10/09/2003US20030188739 High solubility and almost no moisture absorption; improved production efficiency
10/09/2003CA2480578A1 Anomeric derivatives of monosaccharides
10/07/2003US6630579 Complex
10/02/2003WO2003080678A1 Modified saccharides having improved stability in water
10/02/2003WO2003080636A1 A simple process for obtaining beta-aescin from indian horse chestnut (aesculus indica)
10/02/2003WO2003080635A1 Crystals of glucopyranosyloxybenzyl benzene derivative
10/02/2003WO2003080582A2 Fredericamycin derivatives
10/02/2003WO2003080075A1 Ameliorant for chemical treatment of cancer
10/02/2003WO2002030940A3 Low molecular serine protease inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals
10/02/2003US20030187186 Glycopeptide and preparation thereof
10/02/2003US20030186935 Myeloglycan
10/02/2003US20030186890 Amphipathic linear peptides and formulations containing said peptides
10/02/2003US20030185919 Compounds for altering food intake in humans
10/02/2003CA2761440A1 Fredericamycin derivatives
10/01/2003EP1348710A1 Sulfonamide derivatives of 3-substituted imidazo[1,2-D]-1,2,4-thiadiazoles and 3-substituted-[1,2,4]thiadiazolo[4,5-A]benzimidazole as inhibitors of fibrin cross-linking and transglutaminases
10/01/2003EP1347987A1 Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
10/01/2003EP1096994B1 Liquid thickener for surfactant systems
10/01/2003EP0863917B1 Targeted cytotoxic anthracycline analogs
10/01/2003CN1122657C Colchicine skeleton compounds, their use as medicaments and compounds containing them
09/2003
09/30/2003US6627612 Surfactants based upon alkyl polyglycosides
09/28/2003CA2379375A1 Sulfonamide derivatives of 3-substituted imidazol[1,2-d]-1,2,4-thiadiazoles and 3-substituted-[1,2,4] thiadiazolo[4,5-a] benzimidazole as inhibitors of fibrin cross-linking and transglutaminases
09/25/2003WO2003000709A3 Sialic acid derivatives for use as siglec inhibitors
09/25/2003US20030181691 Chromogenic substrates of sialidase and methods of making and using the same
09/25/2003US20030181690 Protecting groups useful in the synthesis of polysaccharides, natural products, and combinatorial libraries
09/25/2003US20030181399 Antagonist inhibiting genetic translation of bacterial, targeting the antibiotic resist strains
09/25/2003US20030181394 Carbobydrates such as alpha-D-galactopyranosyl-1,2-glycerol and/or isomers, obtained by solvent extraction from algae, for use as viricides or anticarcinogenic agents
09/24/2003EP1187839B1 Process for large scale preparation of sphingosines and ceramides
09/23/2003US6624317 Taxoid conjugates as antimitotic and antitumor agents
09/23/2003US6624190 Useful as biodegradable surfactants and in enzymatic processes using a chitinase (N-acetylglucosaminidase)
09/18/2003WO2003053368A3 Chalcone derivatives and their use to treat diseases
09/18/2003US20030176670 Multivalent macrolide antibiotics
09/18/2003US20030175966 Cationic sugar derivatives for gene transfer
09/18/2003US20030175838 Comprises dioxetane compound and phosphatases
09/18/2003US20030175731 Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies
09/17/2003EP1344780A1 Glucopyranosyloxybenzyl benzene derivatives, medicinal compositions containing the same and intermediates in the production thereof
09/17/2003EP1027359B9 Monocyclic l-nucleosides, analogs and uses thereof
09/17/2003EP0914512B1 Process for providing fibres or nonwovens with a hydrophilic coating
09/17/2003EP0909184B1 Targeted drug delivery using sulfonamide derivatives
09/17/2003CN1121375C Oligosaccharide synthesis
09/16/2003US6620921 1,2,3,5,6-penta-O-propanoyl-beta-D-glucofuranose in crystalline form; prepared by reacting D-glucose, boric acid and propanoic anhydride; useful for preparation of glycosides
09/16/2003US6620916 Reacting with amino group of ligand, in presence of transglutaminase, to form an amide bond; lower binding affinity for asialoglycoprotein receptor; accumulates in liver; use as anti-tumor anti-inflammatory and viricide
09/16/2003US6620792 Monosialoganglioside GM1 or a derivative thereof, namely, the inner ester AGF2 and the methyl ester AGF4, suitable for the treatment of Parkinson's disease. A further object of the present invention is a therapy for Parkinson's Disease
09/16/2003CA2131719C Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor
09/16/2003CA2119463C Glial cell line-derived neutrophic factor
09/12/2003WO2003073988A2 Glycuronamides, glycosides and orthoester glycosides of fluoxetine, analogs and uses thereof
09/12/2003WO2002102325A3 Plasma glucosylceramide deficiency as risk factor for thrombosis and modulator of anticoagulant protein c
09/12/2003CA2478093A1 Glycuronamides, glycosides and orthoester glycosides of fluoxetine, analogs and uses thereof
09/11/2003US20030171305 Tetraphenylbacteriochlorin derivatives and compositions containing the same
09/10/2003EP1341800A2 C-glucosyl ether lipids
09/10/2003EP1159237B1 Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use
09/10/2003EP1090023B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
09/10/2003CN1120707C Ligands to enhance cellular uptake of biomolecules
09/09/2003US6617352 Compounds and methods for the inhibition of the expression of VCAM-1
09/04/2003WO2003072858A1 Fibrous nano self-assemblies
09/04/2003WO2003072489A1 Microfine self-aggregate
09/04/2003WO2002074737A3 Process for the preparation of 2-hydroxymethyl-pyrolidine-3,4-diols
09/04/2003US20030166250 Cerebrosides/gangliosides; derived from Pseudomonas or Shewanella
09/04/2003US20030165432 Versatile hydrophilic dyes
09/03/2003EP1340745A1 Indirubin derivatives and their use for the treatment of cancer
09/03/2003EP1340740A1 Carboxylic acid type lipid
09/03/2003EP1339729A2 Anti-inflammatory compounds derived from pseudopterogorgia elisabethae
09/03/2003EP0828748B2 Process for producing light-coloured, low-viscosity alkyl oligoglycosides
09/02/2003US6613879 FAP-activated anti-tumour compounds
09/02/2003US6613748 C-glucosyl ether lipids
08/2003
08/28/2003WO2003070703A2 Hydroxylated indirubin derivatives
08/28/2003WO2003070182A2 Sodium channel blockers
08/28/2003US20030162240 Contacting a chromogenic sialidase substrate with a substitued phenoxoypyran derivative and detecting a visible color change that indicates the presence of a sialidase
08/28/2003US20030161900 Use of a dihydrochalcone-rich phenolic fraction in a cosmetic treatment
08/27/2003EP1338270A2 Use of a dihydrochalcone-rich phenolic fraction in a cosmetic composition
08/27/2003EP1337539A2 Linkable sialyl lewis x analogs
08/27/2003EP1337538A1 Phosphoglycan messengers and their medical uses
08/27/2003EP1011687A4 13-deoxyanthracycline derivatives and processes for preparing them
08/27/2003EP0874809B1 Carbamoyloxy derivatives of mutiline and their use as antibacterials
08/27/2003CN1438882A Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents
08/26/2003US6610835 Compound of given formula; use for treatment of abnormal cell proliferation, tumors, inflammation, psoriasis, inflammatory bowel disease; promotion of cell differentiation, induction of apoptosis, inhibition of protein kinase C
08/26/2003US6610727 Antitumor agents
08/21/2003WO2003068789A1 Substituted inositols and their use
08/21/2003WO2002102416A3 Antiviral glycoconjugates
08/21/2003US20030158243 Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity
08/21/2003US20030157487 Nucleic acid ligands
1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 180